Glass House Brands (GLAS) Tax Provisions (2020 - 2026)
Glass House Brands' (GLAS) quarterly Tax Provisions came in at $3.1 million in Q1 2026, up 3.1% on a QoQ basis from $3.0 million in Q4 2025.
Glass House Brands (GLAS) Tax Provisions (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Tax Provisions data on file, last reported at $3.1 million in Q1 2026.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $12.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $11.9 million, up 13.68% from the prior year.
- Tax Provisions for Q1 2026 stood at $3.1 million, up from $3.0 million in the prior quarter.
- Over the last five years, Tax Provisions for GLAS reached as high as $6.9 million in Q4 2022 and fell as low as -$1.4 million in Q1 2022.
- Historically, Tax Provisions has averaged $2.9 million across 5 years, with a median of $3.0 million in 2025.
- Across the five-year window, Tax Provisions slumped 178.7% in 2022 and surged 2347.78% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $6.9 million in 2022, then plunged by 38.93% to $4.2 million in 2023, then sank by 95.19% to $203000.0 in 2024, then jumped by 1361.08% to $3.0 million in 2025, then gained by 3.1% to $3.1 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.06 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 4.97 Mn |
| Jun 30, 2024 | 203,000.00 |
| Dec 31, 2023 | 4.22 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Dec 31, 2022 | 6.91 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | -1.40 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | 773,000.00 |
| Jun 30, 2021 | 2.49 Mn |
| Mar 31, 2021 | 1.78 Mn |
| Mar 31, 2020 | 566,593.00 |